Volume 13, Issue 3 (10-2014)                   JRUMS 2014, 13(3): 281-292 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Izadi M, Rezvani M, Esmaeilidehaj M. Effects of Intracerebroventricular Administration of Salubrinal-A Protein Synthesis Inhibitor-on Epileptic Seizures Induced by Pentylenetetrazol in Male Rats. JRUMS 2014; 13 (3) :281-292
URL: http://journal.rums.ac.ir/article-1-1969-en.html
Shahid sadoughi University of medical sciences
Full-Text [PDF 259 kb]   (2935 Downloads)     |   Abstract (HTML)  (6041 Views)
Full-Text:   (1498 Views)

Effects of Intracerebroventricular Administration of Salubrinal-A Protein Synthesis Inhibitor-on Epileptic Seizures Induced by Pentylenetetrazol in Male Rats

M. Izadi[1], M.E. Rezvani[2], M. Esmailidehaj[3]

Received: 15/12/2013      Sent for Revision: 01/02/2014      Received Revised Manuscript: 15/04/2014     Accepted: 21/04/2014

Background and Objective: Salubrinal- a protein synthesis inhibitor- plays a crucial role in sleep and neuronal inhibition through the GABA activation. According to these evidences, the aim of the present study was to determine the effect of salubrinal on epileptic seizures induced by pentylenetetrazol (PTZ).

Materials and Methods: In this expremental study under stereotaxical surgery, three monopolar electrodes were fixed on the skull bone of animals and a cannula was implanted in the right cerebral ventricle according to Paxinos coordinates. After 7 days of recovery, each animal received intracerebroventricular (ICV) vehicle, diazepam (0.2 mg/rat) or salubrinal (25 or 50 µg/rat) 10 minutes before Pentylenetetrazol injection (subcutaneous, 60mg/kg). Electrophysiological and behavioral parameters of induced seizures were recorded during 60 minutes.

Results : Salubrinal (25 and 50 µg/rat) significantly retarded the onset of generalized tonic-clonic seizures when compared to vehicle treatment (p<0.05). Epileptic discharge duration and ictal discharge duration were significantly shortened in salubrinal treated rats (p<0.05). Additionally, the rats treated with salubrinal (25 and 50 µg/rat) had lower seizure stage scores, as compared to vehicle treated rats (p<0.05).

Conclusion : The findings of this study revealed that shortly after ICV. administration of salubrinal, epileptic seizures can be significantly decreased. Also, the findings suggest that protein synthesis is an essential process during development of epileptic seizures.

Key words : Seizure, Salubrinal, Protein synthesis inhibitor, Rat, Pentylenetetrazol

Funding: This research was funded by Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Conflict of interest: None declared.

Ethical approval: The Research Committee of Shahid Sadoughi University of Medical Sciences approved the

study.

How to cite this article: Izadi M, Rezvani ME, Esmailidehaj M. Effects of Intracerebroventricular Administration of Salubrinal-A Protein Synthesis Inhibitor-on Epileptic Seizures Induced by Pentylenetetrazol in Male Rats. J Rafsanjan Univ Med Sci 2014; 13(3): 281-92. [Farsi]

 

[1]- MSc of Dept. of Physiology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

[2]- Associate Prof., Dept. of Physiology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

   (Corresponding Author) Tel: (0351) 8203410, Fax: (0351) 8203414, Email: erezvani@yahoo.com

[3]- Associate Prof., Dept. of Physiology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Type of Study: Research | Subject: Physiology
Received: 2013/11/28 | Accepted: 2014/10/18 | Published: 2014/10/18

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Rafsanjan University of Medical Sciences

Designed & Developed by : Yektaweb